Atlanta Cancer Care

Atlanta, Georgia 30342

0 studies enrolling now · 9 studies all time

What they study most

Colorectal Cancer, Esophagus Cancer, Giant Cell Glioblastoma, Glioblastoma, Glioblastoma With Oligodendroglial Component, Gliosarcoma, Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma, Prostate Cancer, Recurrent Glioblastoma, Relapsed Glioblastoma

Studies at this site

• Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma — Completed
• A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer — Completed
• Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer — Completed
• A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma — Completed
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma — Completed
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
• Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer — Completed
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early